Fierce Pharma Homepage

topic report
National Breast Cancer Awareness Month pink ribbon
Favicon Fierce Biotech

After Enhertu: The slow hunt for next-gen HER2 breast cancer drugs

From dual-payload ADCs to bispecifics and radioligands, drugmakers are hunting for answers either after Enhertu progression or to replace it.
Angus Liu Oct 28, 2026 9:00am
Pills medicine in Dollar sign shape on blue background

Drugmakers seek to intervene in hospitals' 340B rebate challenge

Oct 15, 2026 4:20pm
HHS headquarters as seen on April 02 2025

HHS announces vaccine injury research, reporting initiatives

Oct 8, 2026 4:00pm
legal battle lawsuit concept as two justice scales hitting each other
Favicon Fierce Pharma

PhRMA pushes back on CMS' Part B MFN model in court

Oct 8, 2026 8:05am
radiopharmaceutical
Favicon Fierce Pharma

Proposed nuclear rules threaten Novartis’ Pluvicto

Oct 6, 2026 9:00am
Prescription medicine pill expense

HRSA taps Pfizer, AbbVie, others for revised 340B rebate pilot

Oct 2, 2026 1:00pm
More News
Fierce Pharma

Kennedy eases up enforcement on compounding of 6 peptides

Oct 29, 2026 8:12am

CMS finalizes model that brings MFN pricing to Part B

Sep 30, 2026 5:30pm
Fierce Biotech

Overton backs vaccines, mifepristone in confirmation hearing

Sep 24, 2026 2:32pm

White House announces 40 states ink Medicaid drug deals

Sep 21, 2026 1:00pm